• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Development and validation of a visual impairment prediction nomogram in chronic kidney diseases: the National Health and Nutrition Examination Survey, 1999-2008.慢性肾脏病视觉障碍预测列线图的开发与验证:1999 - 2008年美国国家健康与营养检查调查
Int J Ophthalmol. 2025 May 18;18(5):919-924. doi: 10.18240/ijo.2025.05.19. eCollection 2025.
2
Development and validation of a nomogram for predicting depression risk in patients with chronic kidney disease based on NHANES 2005-2018.基于2005 - 2018年美国国家健康与营养检查调查(NHANES)的慢性肾脏病患者抑郁风险预测列线图的开发与验证
J Health Popul Nutr. 2025 Apr 25;44(1):136. doi: 10.1186/s41043-025-00890-7.
3
Development and construction of a cataract risk prediction model based on biochemical indices: the National Health and Nutrition Examination Survey, 2005-2008.基于生化指标的白内障风险预测模型的开发与构建:2005 - 2008年美国国家健康与营养检查调查
Front Med (Lausanne). 2024 Oct 21;11:1452756. doi: 10.3389/fmed.2024.1452756. eCollection 2024.
4
Development and validation of a novel nomogram to predict overall survival of patients with moderate to severe chronic kidney disease.开发和验证一种新的列线图模型,以预测中重度慢性肾脏病患者的总生存情况。
Ren Fail. 2022 Jan 23;44(1):241-249. doi: 10.1080/0886022X.2022.2032744.
5
Establishment, Prediction, and Validation of a Nomogram for Cognitive Impairment in Elderly Patients With Diabetes.建立、预测和验证老年糖尿病患者认知障碍的列线图
J Diabetes Res. 2024 Aug 19;2024:5583707. doi: 10.1155/2024/5583707. eCollection 2024.
6
Risk prediction model of cognitive performance in older people with cardiovascular diseases: a study of the National Health and Nutrition Examination Survey database.心血管疾病老年人认知功能的风险预测模型:基于国家健康与营养检查调查数据库的研究
Front Public Health. 2025 Jan 13;12:1447366. doi: 10.3389/fpubh.2024.1447366. eCollection 2024.
7
Construction and validation of a nomogram for detecting chronic kidney disease in patients with nonalcoholic fatty liver disease: Insights from the NHANES database.非酒精性脂肪性肝病患者慢性肾脏病检测列线图的构建与验证:来自美国国家健康与营养检查调查(NHANES)数据库的见解
Clinics (Sao Paulo). 2025 May 7;80:100686. doi: 10.1016/j.clinsp.2025.100686. eCollection 2025.
8
A novel nomogram for predicting risk of hypertension in US adults with periodontitis: National Health and Nutrition Examination Survey (NHANES) 2009-2014.一种用于预测美国牙周炎成年人高血压风险的新诺莫图:2009-2014 年全国健康和营养检查调查(NHANES)。
Medicine (Baltimore). 2023 Dec 22;102(51):e36659. doi: 10.1097/MD.0000000000036659.
9
Development and validation of a risk nomogram model for predicting pulmonary hypertension in patients with stage 3-5 chronic kidney disease.构建并验证预测 3-5 期慢性肾脏病患者并发肺动脉高压风险的列线图模型。
Int Urol Nephrol. 2023 May;55(5):1353-1363. doi: 10.1007/s11255-022-03431-x. Epub 2022 Dec 23.
10
Construction and validation of a predictive model for the risk of osteoporosis in patients with chronic kidney disease based on NHANES data.基于美国国家健康与营养检查调查(NHANES)数据构建并验证慢性肾病患者骨质疏松风险预测模型
PLoS One. 2025 Feb 6;20(2):e0316494. doi: 10.1371/journal.pone.0316494. eCollection 2025.

本文引用的文献

1
World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Participants.《世界医学协会赫尔辛基宣言:涉及人类受试者的医学研究伦理原则》
JAMA. 2025 Jan 7;333(1):71-74. doi: 10.1001/jama.2024.21972.
2
Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019.1990年至2019年中国慢性肾脏病患病率和死亡率的时间趋势:全球疾病负担研究2019分析
Clin Kidney J. 2022 Oct 10;16(2):312-321. doi: 10.1093/ckj/sfac218. eCollection 2023 Feb.
3
Comparison of trend in chronic kidney disease burden between China, Japan, the United Kingdom, and the United States.中国、日本、英国和美国慢性肾脏病负担趋势比较。
Front Public Health. 2022 Sep 6;10:999848. doi: 10.3389/fpubh.2022.999848. eCollection 2022.
4
Literature review on the cross-link between ocular and renal disease: renin angiotensin aldosterone system is a main actor.眼肾疾病交联的文献综述:肾素-血管紧张素-醛固酮系统是主要参与者。
Eur Rev Med Pharmacol Sci. 2022 Jul;26(13):4774-4788. doi: 10.26355/eurrev_202207_29203.
5
Appraising the causal role of smoking in multiple diseases: A systematic review and meta-analysis of Mendelian randomization studies.评估吸烟在多种疾病中的因果作用:孟德尔随机化研究的系统评价和荟萃分析。
EBioMedicine. 2022 Aug;82:104154. doi: 10.1016/j.ebiom.2022.104154. Epub 2022 Jul 8.
6
Hypertensive eye disease.高血压性眼病。
Nat Rev Dis Primers. 2022 Mar 10;8(1):14. doi: 10.1038/s41572-022-00342-0.
7
Retinal Neurovascular Impairment in Non-diabetic and Non-dialytic Chronic Kidney Disease Patients.非糖尿病和非透析慢性肾脏病患者的视网膜神经血管损伤
Front Neurosci. 2021 Nov 18;15:703898. doi: 10.3389/fnins.2021.703898. eCollection 2021.
8
Association Between Visual Impairment and Depression in Patients Attending Eye Clinics: A Meta-analysis.就诊于眼科诊所的患者的视力障碍与抑郁之间的关联:一项荟萃分析。
JAMA Ophthalmol. 2021 Jul 1;139(7):753-761. doi: 10.1001/jamaophthalmol.2021.1557.
9
Global economic productivity losses from vision impairment and blindness.视力损害和失明造成的全球经济生产力损失。
EClinicalMedicine. 2021 Apr 26;35:100852. doi: 10.1016/j.eclinm.2021.100852. eCollection 2021 May.
10
Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study.30 多年来盲症和远距离及近距离视力损伤流行率的变化趋势:全球疾病负担研究的分析。
Lancet Glob Health. 2021 Feb;9(2):e130-e143. doi: 10.1016/S2214-109X(20)30425-3. Epub 2020 Dec 1.

慢性肾脏病视觉障碍预测列线图的开发与验证:1999 - 2008年美国国家健康与营养检查调查

Development and validation of a visual impairment prediction nomogram in chronic kidney diseases: the National Health and Nutrition Examination Survey, 1999-2008.

作者信息

Tan Yu-He, Li Jia-Qi, Sun Xu-Fang

机构信息

Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Key Laboratory of Otolaryngologic and Ophthalmic Diseases, Wuhan 430030, Hubei Province, China.

出版信息

Int J Ophthalmol. 2025 May 18;18(5):919-924. doi: 10.18240/ijo.2025.05.19. eCollection 2025.

DOI:10.18240/ijo.2025.05.19
PMID:40385111
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12043303/
Abstract

AIM

To develop a nomogram to predict the risk of visual impairment (VI) in patients with chronic kidney disease (CKD).

METHODS

Totally 897 patients with CKD were selected from the National Health and Nutrition Examination Survey (NHANES). The training and validation sets were divided in a 7:3 ratio. Multivariate logistic regression and bidirectional stepwise regression was used to select the factor of developing nomogram. The performance of the nomogram was evaluated by receiver operator characteristic curve, calibration curve and decision curve analysis (DCA).

RESULTS

Age, diastolic blood pressure, glucose, serum creatinine, income at or above poverty, and history of smoking were included in the nomogram. And the area under the receiver operating characteristic curve of the training and validation sets were 0.684 and 0.640, respectively. The fit of the model was demonstrated the calibration curve, and DCA showed the value of clinical application.

CONCLUSION

The nomogram may help to screening the probability of VI in patients with CKD. Larger samples are needed to validate and improve the model to increase its efficacy.

摘要

目的

开发一种列线图以预测慢性肾脏病(CKD)患者视力损害(VI)的风险。

方法

从国家健康与营养检查调查(NHANES)中选取897例CKD患者。训练集和验证集按7:3的比例划分。采用多因素逻辑回归和双向逐步回归来选择列线图的构建因素。通过受试者工作特征曲线、校准曲线和决策曲线分析(DCA)评估列线图的性能。

结果

列线图纳入了年龄、舒张压、血糖、血清肌酐、贫困线及以上收入和吸烟史。训练集和验证集的受试者工作特征曲线下面积分别为0.684和0.640。校准曲线证明了模型的拟合度,DCA显示了其临床应用价值。

结论

该列线图可能有助于筛查CKD患者发生VI的概率。需要更大样本量来验证和改进该模型以提高其效能。